Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease

发明授权

US06562816B2 Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease 失效

标题翻译：取代的杂芳基-7-氮杂[2.2.1]双环庚烷用于治疗疾病

请登陆查看更多内容

专利标题： Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease
专利标题（中）： 取代的杂芳基-7-氮杂[2.2.1]双环庚烷用于治疗疾病
申请号： US10218772

申请日： 2002-08-14
公开(公告)号： US06562816B2

公开(公告)日： 2003-05-13
发明人: Donn G. Wishka , Jason K. Myers , Bruce N. Rogers , Eric Jon Jacobsen , David W. Piotrowski , Jeffrey W. Corbett , Alice L. Bodnar , Vincent E. Groppi, Jr.
申请人： Donn G. Wishka , Jason K. Myers , Bruce N. Rogers , Eric Jon Jacobsen , David W. Piotrowski , Jeffrey W. Corbett , Alice L. Bodnar , Vincent E. Groppi, Jr.
主分类号： A61K315377
IPC分类号： A61K315377

Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease

摘要：

The invention provides compounds of Formula I: compounds of the Formula I: wherein R1, R2, R4, R6, X, and W are defined herein. These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in which &agr;7 is known to be involved.

摘要（中）：

本发明提供式I化合物：式I化合物：其中R 1，R 2，R 4，R 6，X和W如本文所定义。这些化合物可以是药物盐或组合物的形式，可以是纯对映体形式或外消旋混合物，并且可用于用于治疗其中已知α7的疾病或病症的药物。

公开/授权文献

US20030069290A1 SUBSTITUTED-HETEROARYL-7-AZA[2.2.1] BYCYCLOHEPTANES FOR THE TREATMENT OF DESEASE 公开/授权日：2003-04-10

信息查询

Espacenet